Superworth

Bionano Genomics EPS BNGO

Diluted earnings per share by quarter and over the last twelve months, from 2017.

Last 12 months, to Jun 30, 2026
−$3.76
Latest quarter, Q2 FY26
−$0.64
Fiscal year 2025
−$5.50

Bionano Genomics' earnings per share was −$3.76 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.64.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$5.50n/a
FY2024−$93.33n/a
FY2023−$407.40n/a
FY2022−$277.80n/a
FY2021−$156.00n/a
FY2020−$324.00n/a
FY2019−$1410.00n/a
FY2018−$2046.00n/a
FY2017n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.64n/a−$3.76
Q1 FY26−$0.76n/a−$5.11
Q4 FY25−$0.77n/a−$5.50
Q3 FY25−$1.59n/a−$16.98
Q2 FY25−$1.99n/a−$46.31
Q1 FY25−$1.15n/a−$58.73
Q4 FY24−$12.25n/a−$93.33
Q3 FY24−$30.92n/a−$147.08
Q2 FY24−$14.41n/a−$309.36
Q1 FY24−$35.75n/a−$369.35
Q4 FY23−$66.00n/a−$407.40
Q3 FY23−$193.20n/a−$419.40

Against its peers

Companies in Healthcare nearest Bionano Genomics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
BNGOBionano Genomics−$3.76
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ICCCImmucell$0.08−58% a year
KEQUKewaunee Scientific$2.76−33% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Bionano Genomics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.